secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longevity Health Holdings, Inc. (XAGE)
CIK:        0001842939
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0000950170-25-001359
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Carmell to acquire Elevai Skincare assets for ~$1.1M stock, earnout, and assumption of liabilities
--------------------------------------------------------------------------------

- Purchase price includes ~$1.1M in Carmell common stock (with $100K escrow), ~$57K cash on inventory sale, 5% net sales earnout for 5 years, and $500K milestone.
- Assets include product portfolio with trailing 12-month revenue of ~$2.5M, ~$1.0M inventory, commercial team, and accounts receivable.
- Acquisition expected to close by January 17, 2025, subject to customary closing conditions.
- Carmell to issue unregistered shares as closing stock consideration with registration rights within 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842939/000095017025001359/0000950170-25-001359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842939/000095017025001359/ctcx-20241231.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-001359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer